Related News
And another COVID-19 shot is showing good results
Print Edition
AstraZeneca and Oxford University鈥檚 potential COVID-19 vaccine produced a strong immune response in older adults, data published yesterday showed, with researchers expecting to release late-stage trial results by Christmas.
The data, reported in part last month but published in full in The Lancet medical journal yesterday, suggest that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.
鈥淭he robust antibody and T-cell responses seen in older people in our study are encouraging,鈥 said Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group. 鈥淲e hope that this means our vaccine will help to protect some of the most vulnerable people in society, but further research will be needed before we can be sure.鈥
Late-stage, or Phase III vaccine trials are ongoing to confirm the findings, researchers said, and to test whether the vaccine protects against infection with SARS-CoV-2 in a broader range of people, including people with underlying health conditions.
Results of those trials should definitely be known by Christmas, the Oxford Vaccine Group鈥檚 director Andrew Pollard said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
